Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma

British Journal of Cancer

Volumn 109, Issue 3, 2013, Pages 573-581

  Wang, Q ^a   Fiel, M I ^a   Blank, S ^a   Luan, W ^a   Kadri, H ^a   Kim, K W ^a   Manizate, F ^a   Rosenblatt, A G ^a   Labow, D M ^a   Schwartz, M E ^a   Hiotis, S P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; YOUNG ADULT;

EID: 84883184444     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.352     Document Type: Article

References (31)

1. Bralet M-P, Régimbeau J-M, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C, Terris B (2000) Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 french cases. Hepatology 32: 200-204.
2. Brunt EM (2000) Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31: 241-246.
3. Chemin I, Zoulim F (2009) Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 286: 52-59.
4. Chen C-J, Yang H-I, Su J, Jen C-L, You S-L, Lu S-N, Huang G-T, Iloeje UH. Group ftR-HS (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
5. Chen Y-J, Yeh S-H, Chen J-T, Wu C-C, Hsu M-T, Tsai S-F, Chen P-J, Lin C-H (2000) Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119: 431-440.
6. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56(Suppl 1): S75-S87.
7. El-Serag HB (2011) Hepatocellular Carcinoma. N Engl J Med 365: 1118-1127.
8. European Association for the Study of the L, European Organisation for R, Treatment of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56: 908-943.
9. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
10. Gassmann P, Spieker T, Haier J, Schmidt F, Mardin WA, Senninger N (2010) Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg 34: 2442-2451.
11. Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47: 598-607.
12. Hung H-H, Su C-W, Lai C-R, Chau G-Y, Chan C-C, Huang Y-H, Huo T-I, Lee P-C, Kao W-Y, Lee S-D, Wu J-C (2010) Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol Int 4: 691-699.
13. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207.
14. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
15. Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y (2002) Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89: 57-62.
16. Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T (2012) Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol 47: 577-585.
17. Liu C-J, Chen B-F, Chen P-J, Lai M-Y, Huang W-L, Kao J-H, Chen D-S (2006) Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 194: 594-599.
18. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G (2009) Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101: 1066-1082.
19. Lok ASF, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50: 661-662.
20. Nomura F, Ohnishi K, Tanabe Y (1989) Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64: 1700-1707.
21. Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Kitahara S, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Arima Y, Suzuki K, Yoshioka K (2011) Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 46: 1324-1334.
22. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. International Cooperative Study Group on Hepatocellular Carcinoma (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140: 450-458.
23. Peng S-Y, Chen WJ, Lai P-L, Jeng Y-M, Sheu J-C, Hsu H-C (2004) High a-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and b-catenin mutations. Int J Cancer 112: 44-50.
24. Sung F-Y, Jung C-M, Wu C-F, Lin C-L, Liu C-J, Liaw Y-F, Tsai K-S, Yu M-W (2009) Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology 137: 1687-1697.
25. Tretiakova MS, Hart J, Shabani-Rad MT, Zhang J, Gao Z-h (2009) Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. Mod Pathol 22: 1113-1120.
26. Tretiakova MS, Shabani-Rad MT, Guggisberg K, Hart J, Anders RA, Gao Z-h (2010) Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis. Histopathology 56: 683-693.
27. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M (2010) Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal Dig Liver Dis 42: 341-347.
28. Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka Y, Regimbeau JM, Nagorney DM, Do KA, Ellis LM, Curley SA, Pollock RE, Vauthey JN (2002) Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 235: 722-730.
29. Wu C-F, Yu M-W, Lin C-L, Liu C-J, Shih W-L, Tsai K-S, Chen C-J (2008) Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 29: 106-112.
30. Wu J-C, Huang Y-H, Chau G-Y, Su C-W, Lai C-R, Lee P-C, Huo T-I, Sheen IJ, Lee S-D, Lui W-Y (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51: 890-897.
31. Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR (2011) Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 9: 64-70.